Theme: COVID-19 Challenge towards Cardiology,Public Health and safety.
- About Conference
- Why To Attend ?
- Market Analysis
- Sessions / Tracks
- Abstract Submission Criteria & Eligibility
- Past Conference Report
Euro Hypertension-2020 proudly announces the "8th World Congress on Hypertension Primary Health Care and Public Health" which will be held during June 18-19, 2020 Online Webinar, after the brand success of “World Congress on Hypertension and Cardiovascular Diseases”.
Euro Hypertension 2020 will lay a platform for all the scientists, world-class professors, and cardiologists, nephrologist, endocrinologist, psychiatrists, osteopathicians , bariatric, nurses, healthcare professionals to discuss an approach for hypertension and diagnosis, treatment and prevention of elevated blood pressure.
Hypertension is fairly common among the human population and is oft en unregulated; however, uncontrolled increase in blood pressure leaves the individuals at risk to develop heart ailments. According to a report by the World Health Organization in 2018, 1.1 billion people in the world have a raised blood pressure and less than 1 in 5 have it under control. Treatment of cardiovascular disease often requires the administration of numerous medications for long periods of time to patients likely to be old and suffering from a range of co-morbid conditions. This Conference is dedicated to incite discussions that promote innovations and fresh perspectives to the existing research related to cardiovascular diseases and hypertension.
Hypertension meet 2020 is a distinctive forum to assemble worldwide distinguished academics within the field of cardiology, nephropathy, neuropathy, endocrinology, psychiatry , public health professionals, scientists, educational scientists, industry researchers, scholars to exchange concerning state of the art analysis and provides the best chance to reach the biggest gathering of participants from round the world. Conduct displays, distribute and update information concerning the current state of affairs of hypertension treatment and their effects that leads to the downfall of the society. This 2-day event can surely profit and paves the way for the betterment of the globe. Broadly acclaimed speakers, the foremost recent researches and updates in hypertension are the key features of this event.
The benefits provided to the attendees are:
- CME accreditation certificates will be provided to all speakers, delegates and students
- Opportunity to meet world’s renowned at this CME event
- Keynote forums by Prominent Physicians & Professors
- Best platform for Global business and networking opportunities
- Oral/Poster presentations by Young Researchers
- Best poster award for students
According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $23,849.39 Million in 2017 and is estimated to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period.
Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market.
Hypertension is a chronic medical condition during which the blood pressure is elevated to an unsought level. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. Thus, the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the worldwide sales worth of over USD 40 billion, according to the globe Preview 2018 report by valuate drug company.
Some of the key players contributing to the worldwide anti-hypertensive medication market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.
This research report analyses this market counting on its market segments, major geographies, and current market trends. Geographies analysed under this analysis report include
- North America
- Asia Pacific
- Rest of the World
Track 1: Heart Diseases & Heart failure
Hypertension is the systemic condition accompanying high blood pressure. This remains as one of the common medical problems. High blood pressure is a common condition in which the long-term force of the blood against the artery walls is high enough that it may eventually cause health problems, such as heart failure, chronic kidney disease, coronary artery disease, stroke, atrial fibrillation, vision loss, peripheral vascular disease and dementia. There are two types of high blood pressure, such as primary (essential) hypertension, it tends to develop gradually over many years whereas secondary hypertension tends to develop gradually over many years. People with high blood pressure may have symptoms of headache, shortness of breath, nosebleeds, dizziness, chest pain, visual changes, blood in the urine.
The risk factors of high blood pressure includes age, race, obesity, Family history, use of tobacco, high intake of salt and lower intake of potassium, stress and certain chronic conditions.
Hypertension Meetings Europe 2020 | Cardiovascular Disease Meetings Europe 2020 | Stroke Meetings Europe| Hypertension Congress 2020 | Hypertension Conference 2020 | Hypertension Conferences Asia | Heart Congress | Hypertension Conference 2020 | Hypertension conferences Lisbon | Cardiology congress 2020 | 4th International Hypertension Conference & Healthcare, September 10-11, 2020 Zurich, Switzerland | 5th International Conference on Hypertension & Healthcare Conference, October 18-19, 2020 Abu Dhabi, UAE | 3rd Conference on Hypertension and Cardiovascular Diseases Conference, August 20-21, 2020 Toronto, Canada| Heart Congress Lisbon | International Conference On Hypertension & Cardiology conference, October 01-03, 2019, Las Vegas, USA | Hypertension Beijing 2020, September 20-23, 2020 | Public Health Meetings 2020 | 4th European Forum on Hypertension, Gdynia, May 10-12, 2020
Austrian Heart Foundation, British Cardiovascular Society, British Heart Foundation, British Hypertension Society, Irish Nurses Cardiovascular Association, European Society of Hypertension, European Stroke Organisation, Albanian Society of Cardiology, Bosnia and Herzegovina Society of Hypertension, Society for Public Health Education, Global Public Health Program, Mental Health and Psycho-Social Support Network, Movement for Global Mental Health, Mental Health Innovation Network, Mental Health Worldwide, Centre for Global Mental Health, The World Health Organization Mental Health programme, World Federation for Mental Health, The Gulbenkian Global Mental Health Platform, IFRC Reference Centre for Psychosocial Support.
Track 2: Cardiac Nursing and Healthcare
Cardiac nursing is a registered nurse who specializes to work with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses also perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.
Hypertension Conferences Asia | Hypertension Conference 2020 | Stroke Meetings | Hypertension Meetings 2020 | Heart Failure Events 2020 | Stroke Meeting Asia Pacific | Hypertension Congress 2020 | Hypertension Conference 2020 | Heart Congress Lisbon | Heart Congress | Hypertension Conference 2020
American Association of Clinical Research Professionals, International Society of Hypertension, American College of Epidemiology, American Nurses Association, American Public Health Association, American School Health Association, Association of Environmental Health Academic Programs, Association of Occupational and Environmental Clinics, Association of Public Health Laboratories, Association of Schools and Programs of Public Health, American Society for Microbiology, European Society of Hypertension, National Environmental Health Association, Society for Public Health Education, Society for Public Health Education, Global Public Health Program, Mental Health and Psycho-Social Support Network.
Track 3: Pediatric & Geriatric Cardiology
High blood pressure in children and adolescents is one of the most common problems that the children are facing. They may contribute to premature atherosclerosis and the early development of cardiovascular diseases. Pediatric hypertension can be either primary or secondary and they are categorized as prehypertension (between 90th to 95th percentile), stage 1 (95th to 99th percentile plus 5 mmHg) and stage 2 (≥ 99th percentile plus 5 mmHg) hypertension. People who are between 3 to 18 years of age, the prevalence of prehypertension and hypertension was found to be 3.4 % and 3.6 % respectively. Normally a blood pressure values varies by age, sex, and height. Therefore, awareness has to be taken seriously for the diagnosis and treatment of hypertension.
Heart Failure Congress Portugal 2020 | Hypertension Conference 2020 | Hypertension Conference 2020 | Heart Congress | Stroke Meetings 2020 | Cardiology Conference 2020, World Heart Disease Meetings USA | Stroke Meetings Europe 2020 | Cardiology Conferences | Cardiology Conferences 2020 | Heart Failure Conference | Hypertension Conference 2020
Movement for Global Mental Health event, Mental Health Innovation Network, Mental Health Worldwide, Centre for Global Mental Health, The World Health Organization Mental Health programme, World Federation for Mental Health, The Gulbenkian Global Mental Health Platform, IFRC Reference Centre for Psychosocial Support, Sarah Boseley's global health blog + Maternal health, Maternal Health and Maternal Mortality, Rethinking maternal health, Public Health conference, Public Health Agency of Canada, Chinese Center for Disease Control and Prevention, Centre for Health Protection, National Center for disease control, The Japanese Society of Hypertension.
Presenting authors are responsible for registration, hotel costs and travel.
Note: The accepted abstracts will receive an acceptance letter in the mail allowing them to register for the conference.
Abstracts will be compiled and conference books are made available to participants at the conference days.
Any presenter who is unable to attend should arrange for another qualified individual to present the paper in place of the speaker. If such a change is necessary, please notify the program manager
Mail @ [email protected]
Oral paper presentations will have 25-30 minute time slot and be clustered by topic into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute question and answer session.
Graduate & Masters students are eligible to submit their abstracts under poster or oral.
Special certificates will be given to the Student ambassador, Moderators and Best poster award.
Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and oral presentation category.
NOTE: YRF category includes short oral presentation; this offer is subjected mainly for Ph. D. students
Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, critiques or reviews.
Note: Affiliation, Photograph should be attached along with the abstract.
Euro Hypertension 2018 Organizing Committee would like to thank the Moderators of the conference – Dr. Yochai Birnbaum, Baylor College of Medicine, USA and Dr. Ehud Baron, X-Cardio Corp. KK, Japan.
The conference was initiated with a warm welcome note by Yochai Birnbaum and the Keynote forum lead by Ehud Baron, from X-Cardio Corp. KK, Japan.
The highlights of the meeting were the eponymous lectures, delivered by:
- Sandeep Shah, Tarilian Laser Technologies and ViCardio & The Barts Heart Centre, UK
- Nita Shah, Tarilian Laser Technologies and ViCardio, UK
- Percia Bezerra, Nefroclínica Nephrocare, Brazil
- Rola Bou Serhal, Lebanese University, Lebanon
- Laura Marques de Azevedo, SPDM, Brazil
- Mafalda Castelão, Hospital de Santa Maria, Portugal
- Joao Brocas, Tarilian Laser Technologies Ltd (TLT), UK
- Shashi Mawar, AIIMS, India
- Foroohar Foroozan, Analog Devices Inc.(ADI), Canada
- Wafaa Mahmoud Abdel-Rehim, Alexandria University, Egypt
- Remigijus Zaliunas, Lithuanian University of Health Sciences, Lithuania
- Yochai Birnbaum, Baylor College of Medicine, USA & Yumei Ye, University of Texas Medical Branch, USA
- Wala Awad & Anas AbuZaitoun, An Najah National University, Palestine
- Grace M. Egeland, Norwegian Institute of Public Health & University of Bergen, Norway
- Le Fang, Zhejiang Provincial Center for Disease Control and Prevention, China
- Ersin Akpinar, Cukurova University, Turkey
- Marcello Finardi Peixoto, Federal University of Sao Paulo (UNIFESP), Brazil
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums at Hypertension 2018. We sincerely thank the Organizing Committee Members, Editorial Board Members of International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, we would like to announce the commencement of the "8th World Congress on Hypertension Primary Care & Public Health" during June18-19, 2020 at Geneva, Switzerland.
Let us meet again @[email protected]
- Heart Diseases & Heart failure
- Cardiac Nursing and Healthcare
- Pediatric & Geriatric Cardiology
- Pediatric Hypertension
- Heart Diagnosis & Devices
- Obesity in Hypertensive patients
- Cardiovascular Surgeries
- Hypertension in diabetes patients
- Cardiomyopathy & Heart Failure
- Cardiac Nursing
- Women Heart Health
- Congenital Heart Diseases
- Cardiovascular Diseases during Pregnancy
- Current Research in Cardiology
- Clinical Cardiology
- Cardiology and Digital Health
- Cardiovascular Drugs
- Vascular Surgery
To share your views and research, please click here to register for the Conference.